Asthma Free Forever

Asthma Free Forever Ebook

Get Instant Access

1 Anthonisen NR, Connett JE, Kiley JP etal. Effects of smoking intervention and the use of an inhaled anticholinergic bronchodilator on the rate of decline in FEV1: the lung health study. JAMA 1994; 272:1497-505.

2 Moretti M, Lopez-Vidriero MT, Pavia D, Clarke SW. Relationship between bronchial reversibility and tracheobronchial clearance in patients with chronic bronchitis. Thorax 1997; 52: 176-80.

3 Wijnhoven HA, Kriegsman DM, Hesslink AE etal. Determinants of different dimensions of disease severity in asthma and COPD. pulmonary function and health-related quality of life. Chest 2001; 119:1034-42.

4 O'Donnell DE. Assessment of bronchodilator efficacy in sypmtpmatic COPD. is spirometry useful? Chest 2000; 117 (Suppl. 2): 42s-47s.

5 Friedman M, Serby C, Menjoge S etal. Pharmoeconomic evaluation of a combination of ipratropium plus albuterol compared with ipratropium alone and albuterol alone in COPD. Chest 1999; 115: 635-41.

6 Combivent Inhalation Solution Study Group. Routine nebulized ipratropium and albuterol together are better than either alone in COPD. Chest 1997; 112: 1514-21.

7 Boyd G, Morice AH, Poundsford JC etal. An evaluation of salmeterol in the treatment of chronic obstructive pulmonary disease (COPD). Eur Respir J 1997; 10: 815-21.

8 Jones PW, Bosch TK. Quality of life changes in COPD patients treated with salmeterol. Am J Respir Crit Care Med 1997; 155: 1283-9.

9 Mahler DA, Donohue JF, Barbee RA etal. Efficacy of salmeterol xinafoate in the treatment of COPD. Chest 1999; 115: 957-65.

10 Jarvis B, Markham A. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease. Drugs Aging 2001; 18 (6): 441-72.

11 Zu Wallack RL, Mahler DA, Reilly D etal. Salmeterol plus theophylline combination therapy in the treatment of COPD. Chest 2001; 119: 1661-70.

12 Ram FS, Wright J, Brocklebank D, White JES. Systematic review of the clinical effectiveness of pressurized metered dose inhalers versus other hand held inhaler devices for delivering B2 agonist bronchodilators in asthma. BMJ 2001; 323: 901-5.

13 ODriscoll BR. Nebulisers in chronic obstructive pulmonary disease. Thorax 1997; 152 (Suppl. 2): S49-S52 (Part of BTS guidelines on nebuliser use).

14 Boe J, Dennis JH, O'Driscoll BR. European Respiratory Society Guidelines on the use of nebulizers. European Respiratory J 2001; 18: 228-42.

15 Sutton PP, Gemmell HG, Innes N, Davidson J, Smith FW, Legge JS, Friend JAR. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax 1988; 43: 57-60.

16 Poole PJ, Brodie SM, Stewart JM, Black PN. The effects of nebulised isotonic saline and terbutaline on breathlessness in severe chronic obstructive pulmonary disease (COPD). Aust N Z J Medical 1998; 28: 322-6.

17 Mahon JL. Laupacis A, Hodder RV etal. Theophylline for irreversible chronic airflow limitation: a randomized study comparing n of 1 trials to standard practice. Chest 1999; 115: 38-48.

18 Casaburi R, Briggs DD, Donojue JF etal. The spirometric efficacy of once-daily dosing with tiotropium in stable COPD. a 13-week multicenter trial. Chest 2000; 118: 1294-302.

19 Vincken W, van Noord JA, Greefhorst AP et al. Dutch/Belgian Tiotropium Study Group. Improved health outcomes in patients with COPD during 1 year's treatment with tiotropium. Eur Respir J 2002; 19: 209-16.

20 Donohue JF, van Noord JA, Bateman ED et al. A 6-month, placebo-controlled study comparing lung function and health status changes in COPD patients treated with tiotropium or salmeterol. Chest 2002; 122: 47-55.

21 Compton CH, Gubb J, Nieman R etal. Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomized dose-ranging study. Lancet 2001; 358: 265-70.

Was this article helpful?

0 0
Coping with Asthma

Coping with Asthma

If you suffer with asthma, you will no doubt be familiar with the uncomfortable sensations as your bronchial tubes begin to narrow and your muscles around them start to tighten. A sticky mucus known as phlegm begins to produce and increase within your bronchial tubes and you begin to wheeze, cough and struggle to breathe.

Get My Free Ebook

Post a comment